More significant discordance and worse reproducibility were reported among low-expressing cases with PD-L1 around the cutoff of 1% [12], which is made more challenging when attempting to assess whether immune cells are in close enough proximity to the cancer cells to warrant inclusion in scoring. Here, CD274 is linked to cancer.